REGN · Healthcare
Regeneron Pharmaceuticals
33/100
Smart-money confidence1 of 3 sources positive
Below average interest
No standout activity across the feeds we track.
What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Hedge funds
44
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$81.1B
Industry
Biotechnology
Sector
Healthcare
Exchange
NasdaqGS
About REGENERON PHARMACEUTICALS
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent injection to treat atopic dermatitis and asthma;…
Who's behind the signal
Every informed buyer we can see on REGN, across all three feeds.
Hedge funds · 9
Southeastern Asset Mgmt (Longleaf)
Increased +17%
Dodge & Cox
Increased +9%
Gotham Asset Mgmt (Greenblatt)
Increased +27%
Bridgewater Associates (Dalio)
Increased +126%
Renaissance Technologies
Increased +122%
Millennium Management (Englander)
Increased +163%
+3 more in the full breakdown below ↓
Congress · 15
Alan Armstrong
bought
Julia Letlow
bought
Robert P. Bresnahan, Jr.
bought
Byron Donalds
sold
Jefferson Shreve
sold
Julie Johnson
sold
Josh Gottheimer
sold
+7 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 50 on record
Disclosures from 2017-12-18 to 2026-05-15
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-05-15 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2026-03-27 | Alan Armstrong · R-OK | Senate | Bought | $1,001 - $15,000 |
| 2026-02-12 | Julia Letlow · R-LA | House | Bought | $1,001 - $15,000 |
| 2025-11-18 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2025-05-15 | Robert P. Bresnahan, Jr. · R-PA | House | Bought | $1,001 - $15,000 |
| 2025-04-10 | Byron Donalds · R-FL | House | Sold | $1,001 - $15,000 |
| 2025-04-08 | Robert P. Bresnahan, Jr. · R-PA | House | Sold | $1,001 - $15,000 |
| 2025-04-07 | Jefferson Shreve · R-IN | House | Sold | $15,001 - $50,000 |
| 2025-04-01 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-02-25 | Robert P. Bresnahan, Jr. · R-PA | House | Sold | $1,001 - $15,000 |
Show the other 40
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-02-12 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-01-24 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2025-01-15 | Julie Johnson · D-TX | House | Bought | $1,001 - $15,000 |
| 2024-11-29 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2024-11-19 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2024-11-13 | Jonathan L. Jackson · D-IL | House | Sold | $15,001 - $50,000 |
| 2024-11-01 | Jonathan L. Jackson · D-IL | House | Sold | $1,001 - $15,000 |
| 2024-10-23 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2024-10-15 | Greg Landsman · D-OH | House | Sold | $1,001 - $15,000 |
| 2024-07-01 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2024-02-08 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2024-01-17 | Jonathan L. Jackson · D-IL | House | Bought | $1,001 - $15,000 |
| 2023-11-13 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-08-21 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-08-11 | Greg Landsman · D-OH | House | Bought | $1,001 - $15,000 |
| 2023-07-11 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-06-23 | Jonathan L. Jackson · D-IL | House | Bought | $15,001 - $50,000 |
| 2023-06-22 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-03-06 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2022-10-19 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-09-12 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-02-28 | Donald S. Beyer, Jr. · D-VA | House | Sold | $1,001 - $15,000 |
| 2021-09-17 | Donald S. Beyer, Jr. · D-VA | House | Bought | $1,001 - $15,000 |
| 2021-07-21 | Donald S. Beyer, Jr. · D-VA | House | Bought | $1,001 - $15,000 |
| 2021-07-01 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2021-06-17 | Donald S. Beyer, Jr. · D-VA | House | Bought | $1,001 - $15,000 |
| 2021-01-11 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2020-12-22 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-12-11 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-08-14 | Donald S. Beyer, Jr. · D-VA | House | Sold | $1,001 - $15,000 |
| 2020-07-10 | Donald S. Beyer, Jr. · D-VA | House | Sold | $1,001 - $15,000 |
| 2020-05-27 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2020-05-20 | Donald S. Beyer, Jr. · D-VA | House | Bought | $1,001 - $15,000 |
| 2020-05-13 | Dean Phillips · D-MN | House | Sold | $1,001 - $15,000 |
| 2020-04-02 | Dean Phillips · D-MN | House | Sold | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-01-15 | Mikie Sherrill · D-NJ | House | Bought | $1,001 - $15,000 |
| 2019-12-12 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
| 2019-08-21 | Thomas R. Suozzi · D-NY | House | Sold | $1,001 - $15,000 |
| 2017-12-18 | Sheldon Whitehouse · D-RI | Senate | Sold | $15,001 - $50,000 |
Not a model pick — but on our radar.
REGENERON PHARMACEUTICALS isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
0
New positions
8
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
A member of Congress bought
A member sold
Return:
High:
Low:
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
5.0%
Position change
+17%
5.0% of Southeastern Asset Mgmt's portfolio
Trust weight: 1.2×
% of portfolio
1.6%
Position change
+9%
1.6% of Dodge & Cox's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+27%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
+126%
0.1% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+122%
0.1% of Renaissance Technologies's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+163%
0.1% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+69%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+21%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
−8%
0.2% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to REGENERON PHARMACEUTICALS
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Neutral
Sentiment
0
Buys
3
Sells
| Date | Insider | Title | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-10 | Guarini Kathryn | Insider | SELL | 400 | $800.00 | $320,000 |
| 2026-08-10 | Zoghbi Huda Y | Insider | SELL | 800 | $800.00 | $640,000 |
| 2026-07-02 | RYAN ARTHUR F | Insider | SELL | 200 | $650.15 | $130,030 |
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell REGENERON PHARMACEUTICALS or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime